First in human single-ascending dose study to assess Safety, Pharmacokinetic, and the effect of food on ASP8062

Trial Profile

First in human single-ascending dose study to assess Safety, Pharmacokinetic, and the effect of food on ASP8062

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs ASP 8062 (Primary)
  • Indications Fibromyalgia
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 27 Mar 2018 New trial record
    • 24 Mar 2018 Results from two phase I studies assessing safety and pharmacokinetic profile of ASP8062 after single or multiple doses presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top